These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 10474061)
1. A syndrome of psychosis following discontinuation of an estrogen-progestogen contraceptive and improvement following replacement: A case report. Huber TJ; Nickel V; Tröger M; Schneider U; Husstedt H; Emrich HM Neuropsychobiology; 1999; 40(2):75-7. PubMed ID: 10474061 [TBL] [Abstract][Full Text] [Related]
2. Severe exacerbation of psychosis after sudden withdrawal of chlorpromazine in the treatment of methamphetamine-associated psychosis with aripiprazole and chlorpromazine: 2 case reports. Wang G; Devi Thakoor JP; Wang X; Hao W J Addict Med; 2014; 8(6):479-81. PubMed ID: 25303986 [TBL] [Abstract][Full Text] [Related]
3. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation. Mendhekar DN; Jiloha RC Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023 [No Abstract] [Full Text] [Related]
4. Discontinuation of antipsychotic drug therapy. Mitchell JE Psychosomatics; 1981 Mar; 22(3):241-7. PubMed ID: 6111827 [No Abstract] [Full Text] [Related]
5. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse. Moncrieff J Acta Psychiatr Scand; 2006 Jul; 114(1):3-13. PubMed ID: 16774655 [TBL] [Abstract][Full Text] [Related]
6. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up]. Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196 [TBL] [Abstract][Full Text] [Related]
7. Psychotic symptoms following oxycodone withdrawal, case report and update. Casado-Espada NM; Martín C; De La Iglesia-Larrad JI; De Alarcón R; Fombellida CI; Fernández-Martín LC; Roncero C Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6315-6320. PubMed ID: 31364138 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotic withdrawal phenomena in the medical-surgical setting. Dilsaver SC; Coffman JA Gen Hosp Psychiatry; 1988 Nov; 10(6):438-46. PubMed ID: 2904918 [TBL] [Abstract][Full Text] [Related]
9. A case of first-onset psychosis and repeated relapses secondary to discontinuation of non-prescription estrogen replacement therapy in a transgendered female. Moffitt O; Findley JC Gynecol Endocrinol; 2016 Oct; 32(10):796-798. PubMed ID: 27426632 [TBL] [Abstract][Full Text] [Related]
10. Prevention of recurrent menstrual psychosis by an oral contraceptive. Felthous AR; Robinson DB; Conroy RW Am J Psychiatry; 1980 Feb; 137(2):245-6. PubMed ID: 6101529 [TBL] [Abstract][Full Text] [Related]
11. Preliminary findings from the National Register of Antipsychotic Medication in Pregnancy. Kulkarni J; McCauley-Elsom K; Marston N; Gilbert H; Gurvich C; de Castella A; Fitzgerald P Aust N Z J Psychiatry; 2008 Jan; 42(1):38-44. PubMed ID: 18058442 [TBL] [Abstract][Full Text] [Related]
12. Current perspectives on combination oral contraceptives. Smith MA; Youngkin EQ Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284 [TBL] [Abstract][Full Text] [Related]
13. Self-enucleation: forget Freud and Oedipus, it's all about untreated psychosis. Large MM; Nielssen OB Br J Ophthalmol; 2012 Aug; 96(8):1056-7. PubMed ID: 22373824 [TBL] [Abstract][Full Text] [Related]
14. A case of repeated brief psychotic episodes secondary to discontinuation of non-prescription estrogen replacement therapy. Findley JC; Joshi KG Psychosomatics; 2012; 53(3):285-8. PubMed ID: 22305488 [No Abstract] [Full Text] [Related]
15. Managing psychosis in pregnancy. McCauley-Elsom K; Kulkarni J Aust N Z J Psychiatry; 2007 Mar; 41(3):289-92. PubMed ID: 17464711 [TBL] [Abstract][Full Text] [Related]
16. Clozapine-withdrawal catatonia. Wadekar M; Syed S Psychosomatics; 2010; 51(4):355-355.e2. PubMed ID: 20587767 [TBL] [Abstract][Full Text] [Related]
17. Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease. Edlinger M; Seppi K; Fleischhacker W; Hofer A Int Clin Psychopharmacol; 2013 Jul; 28(4):214-6. PubMed ID: 23652781 [TBL] [Abstract][Full Text] [Related]